VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q60547938 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010847.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q60547938‏
024 ‎‡a 0000-0002-7644-3436‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q60547938‏
100 0 ‎‡a Teresa A Almeida‏ ‎‡c researcher ORCID ID = 0000-0002-7644-3436‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Teresa A Almeida‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A high-throughput open-array qPCR gene panel to identify housekeeping genes suitable for myometrium and leiomyoma expression analysis.‏
670 ‎‡a Author's Absence of mutations in DICE1/DDX26 gene in human cancer cell lines with frequent 13q14 deletions.‏
670 ‎‡a Author's Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata‏
670 ‎‡a Author's Analysis of the Expression of Tachykinins and Tachykinin Receptors in the Rat Uterus During Early Pregnancy.‏
670 ‎‡a Author's APC/CTNNB1‏
670 ‎‡a Author's APC/CTNNB1 (?-catenin) pathway alterations in human prostate cancers‏
670 ‎‡a Author's Association between serum substance P levels and mortality in patients with severe sepsis‏
670 ‎‡a Author's Association between serum total antioxidant capacity and mortality in severe septic patients‏
670 ‎‡a Author's B2 exon of the BCR gene is also duplicated in some patients with CML‏
670 ‎‡a Author's Common variants of the neuropeptide expressing tachykinin genes and susceptibility to asthma: A case–control study‏
670 ‎‡a Author's Comparative analysis of the ERα/ERβ ratio and neurotensin and its high-affinity receptor in myometrium, uterine leiomyoma, atypical leiomyoma, and leiomyosarcoma.‏
670 ‎‡a Author's Differential expression of neurokinin B and hemokinin-1 in human immune cells‏
670 ‎‡a Author's Expression of neurokinin B/NK3 receptor and kisspeptin/KISS1 receptor in human granulosa cells.‏
670 ‎‡a Author's Expression of Tachykinins and Tachykinin Receptors and Interaction with Kisspeptin in Human Granulosa and Cumulus Cells.‏
670 ‎‡a Author's HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas‏
670 ‎‡a Author's Improved detection and characterization of mutations by primer addition in nonradioisotopic SSCP and direct PCR sequencing‏
670 ‎‡a Author's Is there any association between nek3 and cancers with frequent 13q14 deletion?‏
670 ‎‡a Author's Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas.‏
670 ‎‡a Author's Organotypic culture as a research and preclinical model to study uterine leiomyomas‏
670 ‎‡a Author's Phylogeography and genetic structure of the Canarian common chaffinch (Fringilla coelebs) inferred with mtDNA and microsatellite loci‏
670 ‎‡a Author's Progression Model of Prostate Cancer‏
670 ‎‡a Author's Serum Levels of Substance P and Mortality in Patients with a Severe Acute Ischemic Stroke‏
670 ‎‡a Author's Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury‏
670 ‎‡a Author's Size-fractionation of RNA by hot agarose electrophoresis.‏
670 ‎‡a Author's Tachykinins and tachykinin receptors: structure and activity relationships‏
670 ‎‡a Author's Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury‏
909 ‎‡a (orcid) 0000000276443436‏ ‎‡9 1‏
919 ‎‡a expressionoftachykininsandtachykininreceptorsandinteractionwithkisspeptininhumangranulosaandcumuluscells‏ ‎‡A Expression of Tachykinins and Tachykinin Receptors and Interaction with Kisspeptin in Human Granulosa and Cumulus Cells.‏ ‎‡9 1‏
919 ‎‡a expressionofneurokininbnk3receptorandkisspeptinkiss1receptorinhumangranulosacells‏ ‎‡A Expression of neurokinin B/NK3 receptor and kisspeptin/KISS1 receptor in human granulosa cells.‏ ‎‡9 1‏
919 ‎‡a differentialexpressionofneurokininbandhemokinin1inhumanimmunecells‏ ‎‡A Differential expression of neurokinin B and hemokinin-1 in human immune cells‏ ‎‡9 1‏
919 ‎‡a comparativeanalysisoftheerαerβratioandneurotensinanditshighaffinityreceptorinmyometriumuterineleiomyomaatypicalleiomyomaandleiomyosarcoma‏ ‎‡A Comparative analysis of the ERα/ERβ ratio and neurotensin and its high-affinity receptor in myometrium, uterine leiomyoma, atypical leiomyoma, and leiomyosarcoma.‏ ‎‡9 1‏
919 ‎‡a commonvariantsoftheneuropeptideexpressingtachykiningenesandsusceptibilitytoasthmaacasecontrolstudy‏ ‎‡A Common variants of the neuropeptide expressing tachykinin genes and susceptibility to asthma: A case–control study‏ ‎‡9 1‏
919 ‎‡a b2exonofthebcrgeneisalsoduplicatedinsomepatientswith950‏ ‎‡A B2 exon of the BCR gene is also duplicated in some patients with CML‏ ‎‡9 1‏
919 ‎‡a associationbetweenserumtotalantioxidantcapacityandmortalityinseveresepticpatients‏ ‎‡A Association between serum total antioxidant capacity and mortality in severe septic patients‏ ‎‡9 1‏
919 ‎‡a associationbetweenserumsubstanceplevelsandmortalityinpatientswithseveresepsis‏ ‎‡A Association between serum substance P levels and mortality in patients with severe sepsis‏ ‎‡9 1‏
919 ‎‡a apcctnnb1cateninpathwayalterationsinhumanprostatecancers‏ ‎‡A APC/CTNNB1 (?-catenin) pathway alterations in human prostate cancers‏ ‎‡9 1‏
919 ‎‡a apcctnnb1‏ ‎‡A APC/CTNNB1‏ ‎‡9 1‏
919 ‎‡a analysisoftheexpressionoftachykininsandtachykininreceptorsintheratuterusduringearlypregnancy‏ ‎‡A Analysis of the Expression of Tachykinins and Tachykinin Receptors in the Rat Uterus During Early Pregnancy.‏ ‎‡9 1‏
919 ‎‡a alteredexpressionofthetachykininssubstancepneurokininahemokinin1andtheirpreferredneurokinin1neurokinin2receptorsinuterineleiomyomata‏ ‎‡A Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata‏ ‎‡9 1‏
919 ‎‡a absenceofmutationsindice1ddx26geneinhumancancercelllineswithfrequent13q14deletions‏ ‎‡A Absence of mutations in DICE1/DDX26 gene in human cancer cell lines with frequent 13q14 deletions.‏ ‎‡9 1‏
919 ‎‡a highthroughputopenarrayqpcrgenepaneltoidentifyhousekeepinggenessuitableformyometriumandleiomyomaexpressionanalysis‏ ‎‡A A high-throughput open-array qPCR gene panel to identify housekeeping genes suitable for myometrium and leiomyoma expression analysis.‏ ‎‡9 1‏
919 ‎‡a improveddetectionandcharacterizationofmutationsby1additioninnonradioisotopicsscpanddirectpcrsequencing‏ ‎‡A Improved detection and characterization of mutations by primer addition in nonradioisotopic SSCP and direct PCR sequencing‏ ‎‡9 1‏
919 ‎‡a isthereanyassociationbetweennek3andcancerswithfrequent13q14deletion‏ ‎‡A Is there any association between nek3 and cancers with frequent 13q14 deletion?‏ ‎‡9 1‏
919 ‎‡a neurotensinandneurotensinreceptor1expressioninhumanmyometriumanduterineleiomyomas‏ ‎‡A Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas.‏ ‎‡9 1‏
919 ‎‡a organotypiccultureasaresearchandpreclinicalmodeltostudyuterineleiomyomas‏ ‎‡A Organotypic culture as a research and preclinical model to study uterine leiomyomas‏ ‎‡9 1‏
919 ‎‡a phylogeographyandgeneticstructureofthecanariancommonchaffinchfringillacoelebsinferredwithmtdnaandmicrosatelliteloci‏ ‎‡A Phylogeography and genetic structure of the Canarian common chaffinch (Fringilla coelebs) inferred with mtDNA and microsatellite loci‏ ‎‡9 1‏
919 ‎‡a progressionmodelofprostatecancer‏ ‎‡A Progression Model of Prostate Cancer‏ ‎‡9 1‏
919 ‎‡a serumlevelsofsubstancepandmortalityinpatientswithasevereacuteischemicstroke‏ ‎‡A Serum Levels of Substance P and Mortality in Patients with a Severe Acute Ischemic Stroke‏ ‎‡9 1‏
919 ‎‡a serumsubstanceplevelsareassociatedwithseverityandmortalityinpatientswithseveretraumaticbraininjury‏ ‎‡A Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury‏ ‎‡9 1‏
919 ‎‡a sizefractionationofrnabyhotagaroseelectrophoresis‏ ‎‡A Size-fractionation of RNA by hot agarose electrophoresis.‏ ‎‡9 1‏
919 ‎‡a tachykininsandtachykininreceptorsstructureandactivityrelationships‏ ‎‡A Tachykinins and tachykinin receptors: structure and activity relationships‏ ‎‡9 1‏
919 ‎‡a totalantioxidantcapacityisassociatedwithmortalityofpatientswithseveretraumaticbraininjury‏ ‎‡A Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury‏ ‎‡9 1‏
919 ‎‡a hmga2andmed12alterationsfrequentlycooccurinuterineleiomyomas‏ ‎‡A HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 PTBNP|1768551‏
996 ‎‡2 ISNI|0000000070737682‏
996 ‎‡2 PTBNP|1417736‏
996 ‎‡2 PTBNP|228629‏
996 ‎‡2 PTBNP|386493‏
996 ‎‡2 ISNI|0000000068479581‏
996 ‎‡2 RERO|A009013451‏
996 ‎‡2 ISNI|0000000027972898‏
996 ‎‡2 DNB|1060758105‏
996 ‎‡2 ISNI|0000000070298181‏
996 ‎‡2 PLWABN|9813648174805606‏
996 ‎‡2 BIBSYS|90527528‏
996 ‎‡2 PTBNP|1689809‏
996 ‎‡2 BNF|14484057‏
996 ‎‡2 PTBNP|1149599‏
996 ‎‡2 ISNI|0000000070126056‏
996 ‎‡2 PTBNP|939215‏
996 ‎‡2 PTBNP|956900‏
996 ‎‡2 SUDOC|132064561‏
996 ‎‡2 BNF|14589481‏
996 ‎‡2 PTBNP|1384046‏
996 ‎‡2 PTBNP|166556‏
996 ‎‡2 PTBNP|1440747‏
996 ‎‡2 CAOONL|ncf11290551‏
996 ‎‡2 DNB|1159199876‏
996 ‎‡2 J9U|987007423802105171‏
996 ‎‡2 LC|n 2011205221‏
996 ‎‡2 ISNI|0000000070617808‏
996 ‎‡2 ISNI|0000000116914905‏
996 ‎‡2 PTBNP|1460042‏
996 ‎‡2 DNB|1056657928‏
996 ‎‡2 LC|n 2010062635‏
996 ‎‡2 PTBNP|1531011‏
996 ‎‡2 SUDOC|267346395‏
996 ‎‡2 PTBNP|129568‏
996 ‎‡2 ISNI|0000000070841295‏
996 ‎‡2 DNB|1214608701‏
996 ‎‡2 BNF|15020071‏
996 ‎‡2 ISNI|0000000118368936‏
996 ‎‡2 LC|no 88000258‏
996 ‎‡2 ISNI|0000000070898929‏
996 ‎‡2 LC|n 2020241355‏
996 ‎‡2 ISNI|0000000090148471‏
996 ‎‡2 PTBNP|1290995‏
996 ‎‡2 ISNI|0000000070627424‏
996 ‎‡2 ISNI|0000000069196428‏
996 ‎‡2 LC|n 00107408‏
996 ‎‡2 BLBNB|001602627‏
996 ‎‡2 SUDOC|178126128‏
996 ‎‡2 ISNI|0000000084959913‏
996 ‎‡2 BNE|XX1062460‏
996 ‎‡2 SUDOC|273696483‏
996 ‎‡2 PTBNP|1477919‏
996 ‎‡2 NUKAT|n 2008038740‏
996 ‎‡2 PTBNP|1016489‏
996 ‎‡2 ISNI|000000013987802X‏
996 ‎‡2 PTBNP|287895‏
996 ‎‡2 PTBNP|1680273‏
996 ‎‡2 BLBNB|001509141‏
996 ‎‡2 PTBNP|1467360‏
996 ‎‡2 SUDOC|125360754‏
996 ‎‡2 ISNI|0000000068915320‏
996 ‎‡2 ISNI|0000000068317179‏
996 ‎‡2 PTBNP|1156717‏
996 ‎‡2 SUDOC|030594170‏
996 ‎‡2 LC|n 2017055442‏
996 ‎‡2 ISNI|0000000116726269‏
996 ‎‡2 SELIBR|175964‏
996 ‎‡2 N6I|vtls000000905‏
996 ‎‡2 DNB|133997243‏
996 ‎‡2 DNB|142772232‏
996 ‎‡2 BNF|16605284‏
996 ‎‡2 ISNI|0000000116107986‏
996 ‎‡2 ISNI|0000000428206051‏
996 ‎‡2 LC|n 98910230‏
996 ‎‡2 PTBNP|285405‏
996 ‎‡2 LC|n 97001720‏
996 ‎‡2 BLBNB|000630249‏
996 ‎‡2 ISNI|0000000387134134‏
996 ‎‡2 DNB|1265217858‏
996 ‎‡2 PTBNP|2307‏
996 ‎‡2 ISNI|0000000037461952‏
996 ‎‡2 LC|no2023050661‏
996 ‎‡2 BLBNB|000485692‏
996 ‎‡2 DNB|1235538524‏
996 ‎‡2 SUDOC|067708463‏
996 ‎‡2 BLBNB|000426669‏
996 ‎‡2 ISNI|0000000079915940‏
996 ‎‡2 NKC|xx0323655‏
996 ‎‡2 LC|nr2005029187‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏